↓ Skip to main content

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

Overview of attention for article published in Radiation Oncology, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
Published in
Radiation Oncology, November 2018
DOI 10.1186/s13014-018-1185-9
Pubmed ID
Authors

Marta Scorsetti, Tiziana Comito, Elena Clerici, Ciro Franzese, Angelo Tozzi, Cristina Iftode, Lucia Di Brina, Pierina Navarria, Pietro Mancosu, Giacomo Reggiori, Antonella Fogliata, Stefano Tomatis, Guido Torzilli, Luca Cozzi

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Other 11 14%
Student > Ph. D. Student 7 9%
Student > Master 7 9%
Student > Postgraduate 6 8%
Other 12 15%
Unknown 22 28%
Readers by discipline Count As %
Medicine and Dentistry 35 44%
Physics and Astronomy 4 5%
Engineering 2 3%
Arts and Humanities 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 7 9%
Unknown 29 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2018.
All research outputs
#4,147,168
of 13,976,883 outputs
Outputs from Radiation Oncology
#231
of 1,422 outputs
Outputs of similar age
#138,466
of 368,467 outputs
Outputs of similar age from Radiation Oncology
#39
of 160 outputs
Altmetric has tracked 13,976,883 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,422 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 160 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.